The Merck Group

Ready to go

A new partner to the life sciences sector is ready to start operations. Merck Millipore will focus on the rapidly growing and highly profitable marketmore

A new partner to the life sciences sector is ready to start operations. Merck Millipore will focus on the rapidly growing and highly profitable market of biopharmaceutical research and production. The new division will offer pharmaceutical and biopharmaceutical customers integrated solutions extending beyond the existing Chemicals portfolio, thereby creating new opportunities for growth.

More Information

A PhD student from Jena in the Preclinical Research Department at Merck, is focusing on a video camera of the NST (Nanovolume Synthesis & Testing) system.

Q2/2010: Merck Profit After Tax Jumps 70%

All four divisions of the Merck Group, especially the Chemicals divisions, recorded increases in second-quarter 2010 revenues, leading to a record EURmore

All four divisions of the Merck Group, especially the Chemicals divisions, recorded increases in second-quarter 2010 revenues, leading to a record EUR 2,208 million in total revenues for the Group. This was a 16% increase compared to the year-ago amount of EUR 1,910 million. In the first half of 2010, total revenues rose 14% to EUR 4,307 million.

More Information

CONTACT FINDER

The best of both worlds

The right balance between Pharmaceuticals and Chemicals as well as innovation and tradition – that’s what we stand for at Merck. Around 40,000 employees worldwide are pursuing the “Sustain. Change. Grow.” strategy to continue the Merck success story – and improve quality of life for people everywhere.